|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9 HKD | 0.00% |
|
+5.88% | -60.35% |
| Apr. 24 | Cstone Pharmaceuticals Logs Lower Loss for 2023, Shares Up By Nearly 5% | MT |
| Apr. 23 | CStone Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
CStone Pharmaceuticals reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 261.47 million compared to CNY 261.77 million a year ago. Net loss was CNY 209.23 million compared to CNY 361.57 million a year ago.
Basic loss per share from continuing operations was CNY 0.17 compared to CNY 0.31 a year ago. Diluted loss per share from continuing operations was CNY 0.17 compared to CNY 0.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -60.35% | 146M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
CSTONE PHARMACEUTICALS 
